peptide sciences shut down FAQ

The Peptide Sciences shut down does not mean the peptide market has disappeared. It means that the vendor landscape has thinned and due diligence matters more than it did before. Here is what to look for when evaluating a replacement supplier.

To understand why Peptide Sciences shut down, you have to zoom out and look at the broader regulatory environment. The research peptide market has been under increasing pressure for several years. But starting in late 2023, enforcement began accelerating. The FDA added 19 peptides to its Category 2 list, which effectively prohibited licensed compounding pharmacies from preparing them. The list included BPC-157 , TB-500, and other widely used compounds. The agency cited concerns about immunogenicity, manufacturing impurities, and the absence of formal clinical trial data in its decision. In March 2024, Eli Lilly filed an International Trade Commission complaint against twelve vendors selling imported tirzepatide. By January 2025, the ITC issued a General Exclusion Order blocking all trademark-infringing tirzepatide imports. That same month, the FDA declared the semaglutide shortage resolved, removing the legal compounding exemption that had allowed pharmacies to prepare it. By December 2024, the FDA had issued warning letters to four peptide vendors directly: Prime Peptides, Xcel Peptides, SwissChems, and Summit Research. In June 2025, the FDA raided the warehouse of Amino Asylum, taking the site offline. The message being sent to every vendor operating in this space was unambiguous. Peptide Sciences appears to have read that environment and made a calculated decision to exit before becoming the subject of an enforcement action. Whether additional legal pressure was applied privately is not publicly known, but the timing and the terse voluntary closure statement are consistent with a company retreating from an increasingly untenable position.

For many buyers, Peptide Sciences was the first name that came up when looking for research peptides in the United States. The company built its reputation on a broad catalog that covered most of the compounds circulating in the research community. That included growth hormone secretagogues, tissue repair peptides, fat-loss compounds, and later GLP-1 analogues like semaglutide and retatrutide. Compared to smaller vendors, the site looked polished and professional. Orders typically shipped on time, packaging was consistent, and customer service generally responded when issues came up. That combination of presentation and reliability made Peptide Sciences something of a default option. In a market where quality can vary wildly, it was often viewed as one of the safer starting points. Like most companies operating in the space, the products were labeled strictly as research chemicals and not intended for human consumption.

The official message left on the Peptide Sciences homepage was extremely brief. It read: That was the entire announcement. No timeline, explanation, or guidance for customers with open orders or store credit. Support channels also stopped responding around the same time, leaving tons of customers unsure whether pending transactions would be completed. The wording of that message matters. The company described the shutdown as voluntary , but within the context of what has been happening across the peptide industry, most observers interpret that phrase differently. In many cases, “voluntary” closures happen when companies recognize that enforcement action is likely and choose to exit before regulators force the issue.

Disclaimer: Muscle and Brawn is an informational resource. This article does not constitute legal, medical, or purchasing advice. The regulatory landscape described reflects information available as of March 2026 and is subject to change. Peptide use outside of licensed medical channels carries legal and health risks. Consult a licensed physician before beginning any peptide protocol.

The honest answer is that we don’t know, but we aren’t keeping our hopes up. When a vendor in this space shuts down abruptly without a transition plan or public communication, customers with outstanding orders or store balances are typically left with no recourse. Peptide Sciences has not announced any refund process or timeline. If you placed an order that was not fulfilled, your best option is to contact your bank or credit card provider and dispute the charge as soon as possible. Depending on how much time has passed since the transaction and the policies of your financial institution, a chargeback may still be possible.